Medical News

Singapore has withdrawn its travel ban on Ten African countries due to the COVID-19 Omicron variant’s increased transmissibility. However, the country’s authorities have warned that a fresh wave of local cases is expected “soon.”Passengers travelling in Singapore with a travel history to Nigeria, Ghana, South Africa, Malawi, Zimbabwe, Namibia, Lesotho, Mozambique, Eswatini, or Botswana, during […]

Ever since the onset of the dry season in the state, the Nasarawa State Government has confirmed two cases of Lassa fever. Dr Janet Angbazo, the Permanent Secretary of the Ministry of Health announced the news at a press conference in Lafia on Friday.The two infected people, according to Angbazo, are being treated in medical

Travellers from Nigeria, Egypt, and Malawi have been barred from entering Canada due to concerns about the spread of the new Omicron COVID-19 variant. Remember that the World Health Organization labelled B.1.1.529 as an Omicron variant and classified it as a concern variant last Friday. Since then, it’s been discovered in a lot of countries

The National Agency for Food and Drug Administration and Control (NAFDAC) announced over the weekend that it had discovered two warehouses in Lagos’ Trade Fair Complex loaded with N3 billion worth of counterfeit drugs and children’s cereals collected from disposal sites.  Prof. Mojisola Adeyeye, the Director General of NAFDAC, announced at a press conference held

Each year on November 14th, World Diabetes Day honors the birth of Sir Frederick Banting, who together along with Charles Herbert Best identified the insulin hormone in 1922. Statistics indicate that 463 million people across the world suffer from diabetes, with Type-2 diabetes making up for 90percent of the total of cases. According to health

The United kingdom medicines regulator has approved the first tablet meant to treat symptomatic Covid. The Molnupiravir tablet will be administered twice a day to patients who have just been diagnosed with coronavirus. The drug, which was originally designed to treat the flu, was shown in clinical trials to reduce the risk of hospitalisation or

Pfizer announced On Monday that its COVID-19 vaccine is safe and effective for children aged 5 to 11 and will eventually seek United states authorization for this age group. The vaccine, developed by Pfizer and its German partner BioNTech, is already accessible to anybody aged 12 and above. However, with children returning to school and